Jim Simons Synlogic, Inc. Transaction History

Renaissance Technologies LLC

$56.7 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.42 - $0.68 $51,408 - $83,232	122,400 Added 133.19%	214,300 $92,000
Q1 2023 May 12, 2023	SELL	$0.56 - $1.07 $2,520 - $4,815	-4,500 Reduced 4.67%	91,900 $58,000
Q4 2022 Feb 13, 2023	SELL	$0.58 - $17.99 $11,136 - $345,407	-19,200 Reduced 16.61%	96,400 $73,000
Q3 2022 Nov 14, 2022	BUY	$0.91 - $14.63 $55,146 - $886,578	60,600 Added 110.18%	115,600 $110,000
Q2 2022 Aug 12, 2022	BUY	$0.89 - $2.47 $3,293 - $9,139	3,700 Added 7.21%	55,000 $63,000
Q1 2022 May 13, 2022	SELL	$1.63 - $2.55 $5,542 - $8,670	-3,400 Reduced 6.22%	51,300 $123,000
Q4 2021 Feb 11, 2022	SELL	$2.27 - $3.0 $304,116 - $401,916	-133,972 Reduced 71.01%	54,700 $132,000
Q3 2021 Nov 12, 2021	SELL	$2.45 - $4.1 $184,776 - $309,217	-75,419 Reduced 28.56%	188,672 $575,000
Q2 2021 Aug 13, 2021	SELL	$3.0 - $4.39 $148,623 - $217,484	-49,541 Reduced 15.8%	264,091 $1.03 Million
Q1 2021 May 13, 2021	SELL	$2.2 - $5.05 $78,474 - $180,133	-35,670 Reduced 10.21%	313,632 $1.12 Million
Q4 2020 Feb 10, 2021	BUY	$1.85 - $2.54 $137,961 - $189,417	74,574 Added 27.14%	349,302 $754,000
Q3 2020 Nov 13, 2020	SELL	$1.85 - $2.57 $269,580 - $374,497	-145,719 Reduced 34.66%	274,728 $555,000
Q2 2020 Aug 13, 2020	BUY	$1.59 - $2.51 $613,700 - $968,797	385,975 Added 1119.68%	420,447 $854,000
Q1 2020 May 14, 2020	SELL	$1.39 - $3.19 $370,852 - $851,092	-266,800 Reduced 88.56%	34,472 $59,000
Q4 2019 Feb 13, 2020	BUY	$1.96 - $2.81 $289,296 - $414,756	147,600 Added 96.05%	301,272 $777,000
Q3 2019 Nov 13, 2019	BUY	$2.12 - $9.37 $259,640 - $1.15 Million	122,472 Added 392.54%	153,672 $352,000
Q2 2019 Aug 12, 2019	BUY	$6.27 - $9.48 $101,574 - $153,576	16,200 Added 108.0%	31,200 $284,000
Q1 2019 May 14, 2019	BUY	$7.01 - $10.24 $105,150 - $153,600	15,000 New	15,000 $114,000

Others Institutions Holding SYBX

# of Institutions

Shares Held

25.5K

Call Options Held

Put Options Held

View Full List

About SYNLOGIC, INC.

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

More about SYBX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account